Late stent thrombosis in a patient with
Recurrent thrombotic events still occur despite dual antiplatelet therapy in patient's post percutaneous coronary intervention (PCI) could be attributed to high on-treatment platelet reactivity. A 44-year-old male, who had staged PCI to left anterior descending (LAD) 2 weeks after an anterior M...
Gespeichert in:
Veröffentlicht in: | Pharmacogenomics 2018-10, Vol.19 (15), p.1151-1157 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recurrent thrombotic events still occur despite dual antiplatelet therapy in patient's post percutaneous coronary intervention (PCI) could be attributed to high on-treatment platelet reactivity.
A 44-year-old male, who had staged PCI to left anterior descending (LAD) 2 weeks after an anterior MI, with a drug-coated stent was readmitted with new anterior STEMI 35 days later. Coronary angiogram revealed mid-stent thrombus
. He had further uncomplicated PCI. Platelet function testing and genotyping showed clopidogrel high on-treatment platelet reactivity and
genotype. Ticagrelor was commenced.
This case study is the first reported in Malaysia to document a patient with a
genotype presenting with a stent thrombosis after an uncomplicated index PCI procedure. |
---|---|
ISSN: | 1462-2416 1744-8042 |
DOI: | 10.2217/pgs-2018-0082 |